HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 291/3/F530    most recent 00370.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Bergsland, K. J. Articles by Coe, F. L. Search for Related Content PubMed PubMed Citation Articles by Bergsland, K. J. Articles by Coe, F. L.

TRANSLATIONAL PHYSIOLOGY

Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers

¹Litholink Corporation and ²University of Chicago, Chicago, Illinois

Submitted 12 September 2005 ; accepted in final form 29 March 2006

We have investigated urine protein inhibitors of calcium oxalate crystallization to determine whether variations in these proteins are associated with kidney stone disease and whether protein measurements improve the identification of stone formers compared with conventional risk factors (RF). Using Western blotting, we studied variations in the electrophoretic mobility patterns and relative abundances of crystallization-inhibitory proteins in urine from 50 stone-forming (SF) and 50 non-stone-forming (NS) first-degree relatives of calcium SF patients, matched by gender and age. Standard urine chemistry stone risk measurements were also made. Multivariate discriminant analysis was used to test the association of these proteins with nephrolithiasis. Differences in form and abundance of several urine proteins including inter--trypsin inhibitor (ITI), prothrombin fragment 1 (PF1), CD59, and calgranulin B (calB) were found to be associated with stone formation. By multivariate discriminant analysis, measurements of forms of PF1, ITI, and calB in men and ITI and CD59 in women, classified 84% of men and 76% of women correctly by stone status. In contrast, standard urine chemistry RF identified only 70% of men correctly and failed to distinguish female SF from NS. Thus a small subset of protein measurements distinguished SF from NS far better than conventional RF in a population of relatives of calcium SF, illustrating the significant association of these proteins with stone disease. Variations in these proteins may serve as markers of stone disease activity or vulnerability to recurrence and may provide new insights into mechanisms of stone formation.

kidney calculi; crystallization; inhibitor; inter--trypsin inhibitor; prothrombin fragment 1; CD59; calgranulin

This article has been cited by other articles:

				L. Mo, L. Liaw, A. P. Evan, A. J. Sommer, J. C. Lieske, and X.-R. Wu Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1935 - F1943. [Abstract] [Full Text] [PDF]